Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PURNIMA VALLABHANENI

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1316945645
CMS profile
59812
Location
KENDALL PARK, NJ

General Payments · PY2018–2024

$1,324.57

  • Reported across 92 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$257.07

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $257.07 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $168.41 9
Exact Sciences Corporation $46.33 2
Novo Nordisk AS $26.88 2
Boehringer Ingelheim Pharmaceuticals, Inc. $15.45 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $183.85 13
PY2019 $202.32 16
PY2020 $213.89 16
PY2021 $198.99 15
PY2022 $113.32 8
PY2023 $155.13 10
PY2024 $257.07 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $16.14 01/02/2024 Food and Beverage Undisputed 01/23/2026 1105648720 CMS
AstraZeneca Pharmaceuticals LP $16.42 02/06/2024 Food and Beverage Undisputed 01/23/2026 1104330856 CMS
AstraZeneca Pharmaceuticals LP $13.54 02/23/2024 Food and Beverage Undisputed 01/23/2026 1105814511 CMS
AstraZeneca Pharmaceuticals LP $14.68 03/08/2024 Food and Beverage Undisputed 01/23/2026 1104255787 CMS
AstraZeneca Pharmaceuticals LP $44.94 03/22/2024 Food and Beverage Undisputed 01/23/2026 1104261595 CMS
AstraZeneca Pharmaceuticals LP $14.26 03/29/2024 Food and Beverage Undisputed 01/23/2026 1105889187 CMS
AstraZeneca Pharmaceuticals LP $16.80 05/09/2024 Food and Beverage Undisputed 01/23/2026 1105576040 CMS
AstraZeneca Pharmaceuticals LP $13.67 07/17/2024 Food and Beverage Undisputed 01/23/2026 1105584324 CMS
AstraZeneca Pharmaceuticals LP $17.96 10/09/2024 Food and Beverage Undisputed 01/23/2026 1105528216 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.45 09/04/2024 Food and Beverage Undisputed 01/23/2026 1117962000 CMS
Exact Sciences Corporation $29.67 01/30/2024 Food and Beverage Undisputed 01/23/2026 1114938541 CMS
Exact Sciences Corporation $16.66 07/30/2024 Food and Beverage Undisputed 01/23/2026 1114938545 CMS
Novo Nordisk Inc $13.42 01/05/2024 Food and Beverage Undisputed 01/23/2026 1096568542 CMS
Novo Nordisk Inc $13.46 02/09/2024 Food and Beverage Undisputed 01/23/2026 1096831739 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.